Phase II Trial of Oral Vinorelbine in Children With Recurrent or Progressive Unresectable Low-Grade Glioma
Status:
Completed
Trial end date:
2020-10-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to determine whether oral vinorelbine is effective in the
treatment of children with progressive or recurrent unresectable low grade glioma.
Phase:
Phase 2
Details
Lead Sponsor:
Centre Oscar Lambret
Collaborators:
National Cancer Institute, France Pierre Fabre Laboratories